Should Pfizer’s (PFE) Antitrust Settlement and R&D Push Shift Investor Focus on Long-Term Risks?
| Show full article |
|
This functionality is available for registred users only
|
-
Full namePfizer Inc
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









